|Bid||1.600 x 1000|
|Ask||1.920 x 800|
|Day's Range||1.710 - 1.860|
|52 Week Range||1.560 - 10.900|
|PE Ratio (TTM)||-0.44|
|Earnings Date||May 12, 2017 - May 15, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
NEW YORK, NY / ACCESSWIRE / September 13, 2017 / All three major indexes reached record highs Tuesday as investor's concerns over rising geopolitical tensions and damage from hurricanes have subsided. ...
BERKELEY HEIGHTS, N.J., Sept. 08, 2017-- Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage response biology to develop ...
Research Desk Line-up: Cyclacel Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 16, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...